Mario R Ehlers

Summary

Publications

  1. pmc Mycosin-1, a subtilisin-like serine protease of Mycobacterium tuberculosis, is cell wall-associated and expressed during infection of macrophages
    Joel A Dave
    Department of Medical Biochemistry, University of Cape Town Medical School, Observatory 7925, Cape Town, South Africa
    BMC Microbiol 2:30. 2002
  2. ncbi request reprint Recombinant glucagon-like peptide-1 (7-36 amide) lowers fasting serum glucose in a broad spectrum of patients with type 2 diabetes
    M R Ehlers
    Restoragen, Inc, Lincoln, Nebraska, USA
    Horm Metab Res 35:611-6. 2003
  3. ncbi request reprint Pacific biomarkers, inc
    Mario R Ehlers
    Pacific Biomarkers, Inc, 220 West Harrison Street, Seattle, WA 98119, USA
    Biomark Med 2:221-7. 2008

Collaborators

  • Joel A Dave
  • Albert D Beyers
  • Gordon D Brown
  • Nico C Gey van Pittius

Detail Information

Publications3

  1. pmc Mycosin-1, a subtilisin-like serine protease of Mycobacterium tuberculosis, is cell wall-associated and expressed during infection of macrophages
    Joel A Dave
    Department of Medical Biochemistry, University of Cape Town Medical School, Observatory 7925, Cape Town, South Africa
    BMC Microbiol 2:30. 2002
    ..bovis BCG (bacille de Calmette et Guérin) and was selected for further analyses due to the absence of expression in this organism...
  2. ncbi request reprint Recombinant glucagon-like peptide-1 (7-36 amide) lowers fasting serum glucose in a broad spectrum of patients with type 2 diabetes
    M R Ehlers
    Restoragen, Inc, Lincoln, Nebraska, USA
    Horm Metab Res 35:611-6. 2003
    ..c.) via bolus injection or continuous infusion to lower fasting serum glucose (FSG) levels in subjects with type 2 diabetes treated by diet, hypoglycemic drugs, or insulin injection...
  3. ncbi request reprint Pacific biomarkers, inc
    Mario R Ehlers
    Pacific Biomarkers, Inc, 220 West Harrison Street, Seattle, WA 98119, USA
    Biomark Med 2:221-7. 2008
    ..Pacific Biomarkers was created to provide biomarker testing services for clinical drug development, specifically in the areas of ligand-binding assays, multiplexing and immunogenicity testing, in a regulatory-compliant environment...